Novocure Announces Fourth Quarter and Full Year 2020 Preliminary Net Revenues and Provides Company Update

Novocure (NASDAQ: NVCR) today reported operating statistics and preliminary, unaudited net revenues and cash balances for the fourth quarter and full year 2020. Novocure plans to discuss these results with investors at the 39^th Annual J.P. Morgan Virtual Healthcare Conference. Novocure also plans to highlight key clinical and product development programs.

Fourth quarter and full year 2020 highlights include:

Three months ended December 31,

Twelve months ended December 31,

2020

2019

% Change

2020

2019

% Change

(unaudited)

(audited)

Novocure NASDAQ:NVCR NVCR Rankings N/A Ranked by Market Cap N/A Ranked by Dividends NVCR Latest News Apr 24, 2025 Novocure Reports First Quarter 2025 Financial Results Apr 22, 2025 Novocure’s Optune Lua® Receives CE Mark Approval for the Treatment of Metastatic Non-Small Cell Lung Cancer Apr 1, 2025 Novocure to Report First Quarter 2025 Financial Results Mar 4, 2025 Novocure to Participate in Leerink Partners 2025 Global Healthcare Conference Feb 27, 2025 Novocure Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Company Update NVCR Stock Data Market Cap 1.94B Float 100.43M Insiders Ownership 9.78% Institutions Ownership 84.86% Short Percent 4.75% Industry Medical Devices Sector Surgical & Medical Instruments & Apparatus Website Link Country Switzerland City ST. HELIER Explore About Rhea-AI Sitemap Legal Terms of Use Cookie Notice Privacy Policy Links RSS feed Discord Server Facebook Reddit © 2020-2025 StockTitan.net Login Please enter your login and password Email address Password Forgot password? LOGIN Close Don't have an account? Sign Up! Forgot Password Please enter your email address Email address RECOVER Close Sign Up To create a free account, please fill out the form below. Username Email address Password I accept the user agreement Sign me up for the newsletter CREATE ACCOUNT Close Already have an account? Login